Wednesday, April 1, 2020

Novartis scraps sale of assets to Aurobindo Pharma after failing to get FTC nod

Novartis scraps sale of assets to Aurobindo Pharma after failing to get FTC nod Novartis said the decision to terminate the sale of Sandoz US#39;s generic oral solids and dermatology businesses was taken after the companies did not get approval from the U.S. Federal Trade Commission within anticipated timelines.

from Moneycontrol Business News https://ift.tt/2X3yjLJ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin won over Wall Street and now it’s paying the price

Bitcoin's integration with American finance brought stability but created a new weakness. Institutional investors expected Bitcoin to he...